nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—CYP2C8—Sorafenib—thyroid cancer	0.102	0.216	CbGbCtD
Gemfibrozil—CYP2C19—Sorafenib—thyroid cancer	0.0852	0.181	CbGbCtD
Gemfibrozil—CYP1A2—Sorafenib—thyroid cancer	0.0786	0.167	CbGbCtD
Gemfibrozil—CYP2C9—Sorafenib—thyroid cancer	0.0708	0.151	CbGbCtD
Gemfibrozil—CYP3A4—Vandetanib—thyroid cancer	0.0683	0.145	CbGbCtD
Gemfibrozil—CYP3A4—Sorafenib—thyroid cancer	0.0412	0.0875	CbGbCtD
Gemfibrozil—CYP3A4—Doxorubicin—thyroid cancer	0.025	0.0531	CbGbCtD
Gemfibrozil—PPARA—RXR and RAR heterodimerization with other nuclear receptor—THRB—thyroid cancer	0.00798	0.062	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptors—THRB—thyroid cancer	0.00589	0.0457	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00466	0.0361	CbGpPWpGaD
Gemfibrozil—PPARA—PPAR Alpha Pathway—CDK1—thyroid cancer	0.00365	0.0284	CbGpPWpGaD
Gemfibrozil—PPARA—REV-ERBA represses gene expression—RXRA—thyroid cancer	0.00361	0.0281	CbGpPWpGaD
Gemfibrozil—PPARA—RORA activates circadian gene expression—RXRA—thyroid cancer	0.0035	0.0272	CbGpPWpGaD
Gemfibrozil—PPARA—RXR and RAR heterodimerization with other nuclear receptor—RXRA—thyroid cancer	0.00339	0.0263	CbGpPWpGaD
Gemfibrozil—PPARA—PPAR Alpha Pathway—RXRA—thyroid cancer	0.00339	0.0263	CbGpPWpGaD
Gemfibrozil—Pancreatitis—Vandetanib—thyroid cancer	0.00311	0.00777	CcSEcCtD
Gemfibrozil—PPARA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—RXRA—thyroid cancer	0.00311	0.0241	CbGpPWpGaD
Gemfibrozil—Photosensitivity reaction—Vandetanib—thyroid cancer	0.0029	0.00724	CcSEcCtD
Gemfibrozil—Weight decreased—Vandetanib—thyroid cancer	0.00287	0.00717	CcSEcCtD
Gemfibrozil—Depression—Vandetanib—thyroid cancer	0.00282	0.00705	CcSEcCtD
Gemfibrozil—SLCO1B1—Recycling of bile acids and salts—RXRA—thyroid cancer	0.00282	0.0219	CbGpPWpGaD
Gemfibrozil—Renal failure—Vandetanib—thyroid cancer	0.00278	0.00695	CcSEcCtD
Gemfibrozil—Eczema—Sorafenib—thyroid cancer	0.00276	0.00689	CcSEcCtD
Gemfibrozil—Urinary tract infection—Vandetanib—thyroid cancer	0.00275	0.00687	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00268	0.00669	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00263	0.00656	CcSEcCtD
Gemfibrozil—Peripheral vascular disorder—Epirubicin—thyroid cancer	0.00257	0.00642	CcSEcCtD
Gemfibrozil—PPARA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RXRA—thyroid cancer	0.00256	0.0198	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptors—RXRA—thyroid cancer	0.0025	0.0194	CbGpPWpGaD
Gemfibrozil—PPARA—Activation of gene expression by SREBF (SREBP)—RXRA—thyroid cancer	0.0024	0.0186	CbGpPWpGaD
Gemfibrozil—Peripheral vascular disorder—Doxorubicin—thyroid cancer	0.00238	0.00594	CcSEcCtD
Gemfibrozil—Eye disorder—Vandetanib—thyroid cancer	0.00238	0.00593	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Vandetanib—thyroid cancer	0.00229	0.00572	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Sorafenib—thyroid cancer	0.00226	0.00565	CcSEcCtD
Gemfibrozil—Alopecia—Vandetanib—thyroid cancer	0.00225	0.00561	CcSEcCtD
Gemfibrozil—Breast disorder—Sorafenib—thyroid cancer	0.00224	0.00559	CcSEcCtD
Gemfibrozil—Mental disorder—Vandetanib—thyroid cancer	0.00223	0.00556	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Sorafenib—thyroid cancer	0.00222	0.00553	CcSEcCtD
Gemfibrozil—PPARA—Transcriptional activation of mitochondrial biogenesis—RXRA—thyroid cancer	0.00219	0.017	CbGpPWpGaD
Gemfibrozil—Dysgeusia—Vandetanib—thyroid cancer	0.00217	0.00541	CcSEcCtD
Gemfibrozil—PPARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—thyroid cancer	0.00214	0.0166	CbGpPWpGaD
Gemfibrozil—Pancreatitis—Sorafenib—thyroid cancer	0.0021	0.00524	CcSEcCtD
Gemfibrozil—Vision blurred—Vandetanib—thyroid cancer	0.00209	0.00521	CcSEcCtD
Gemfibrozil—Myasthenia—Epirubicin—thyroid cancer	0.00201	0.00501	CcSEcCtD
Gemfibrozil—PPARA—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00198	0.0154	CbGpPWpGaD
Gemfibrozil—Erectile dysfunction—Sorafenib—thyroid cancer	0.00197	0.00493	CcSEcCtD
Gemfibrozil—Loss of consciousness—Vandetanib—thyroid cancer	0.00194	0.00486	CcSEcCtD
Gemfibrozil—Weight decreased—Sorafenib—thyroid cancer	0.00194	0.00484	CcSEcCtD
Gemfibrozil—Cough—Vandetanib—thyroid cancer	0.00193	0.00482	CcSEcCtD
Gemfibrozil—PPARA—Regulation of cholesterol biosynthesis by SREBP (SREBF)—RXRA—thyroid cancer	0.00192	0.0149	CbGpPWpGaD
Gemfibrozil—Convulsion—Vandetanib—thyroid cancer	0.00192	0.00479	CcSEcCtD
Gemfibrozil—PPARA—Mitochondrial biogenesis—RXRA—thyroid cancer	0.00189	0.0147	CbGpPWpGaD
Gemfibrozil—Chest pain—Vandetanib—thyroid cancer	0.00188	0.0047	CcSEcCtD
Gemfibrozil—Arthralgia—Vandetanib—thyroid cancer	0.00188	0.0047	CcSEcCtD
Gemfibrozil—Renal failure—Sorafenib—thyroid cancer	0.00188	0.00469	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00187	0.00467	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00187	0.00467	CcSEcCtD
Gemfibrozil—Bone marrow depression—Epirubicin—thyroid cancer	0.00187	0.00467	CcSEcCtD
Gemfibrozil—PPARA—Circadian Clock—RXRA—thyroid cancer	0.00186	0.0145	CbGpPWpGaD
Gemfibrozil—Jaundice—Sorafenib—thyroid cancer	0.00186	0.00465	CcSEcCtD
Gemfibrozil—Myasthenia—Doxorubicin—thyroid cancer	0.00186	0.00464	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00181	0.00451	CcSEcCtD
Gemfibrozil—Oedema—Vandetanib—thyroid cancer	0.00181	0.00451	CcSEcCtD
Gemfibrozil—CYP2C8—Arachidonic acid metabolism—HPGD—thyroid cancer	0.0018	0.014	CbGpPWpGaD
Gemfibrozil—Nervous system disorder—Vandetanib—thyroid cancer	0.00177	0.00442	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Vandetanib—thyroid cancer	0.00177	0.00441	CcSEcCtD
Gemfibrozil—Skin disorder—Vandetanib—thyroid cancer	0.00175	0.00438	CcSEcCtD
Gemfibrozil—Bone marrow depression—Doxorubicin—thyroid cancer	0.00173	0.00432	CcSEcCtD
Gemfibrozil—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.00173	0.0134	CbGpPWpGaD
Gemfibrozil—Neuritis—Epirubicin—thyroid cancer	0.00169	0.00422	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Sorafenib—thyroid cancer	0.00168	0.00421	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00165	0.00411	CcSEcCtD
Gemfibrozil—PPARA—Circadian rythm related genes—NKX2-1—thyroid cancer	0.00163	0.0126	CbGpPWpGaD
Gemfibrozil—Paraesthesia—Vandetanib—thyroid cancer	0.00162	0.00405	CcSEcCtD
Gemfibrozil—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00161	0.0125	CbGpPWpGaD
Gemfibrozil—Hyperaesthesia—Epirubicin—thyroid cancer	0.00161	0.00401	CcSEcCtD
Gemfibrozil—Dyspepsia—Vandetanib—thyroid cancer	0.00159	0.00397	CcSEcCtD
Gemfibrozil—PPARA—Nuclear Receptors—PPARG—thyroid cancer	0.00158	0.0123	CbGpPWpGaD
Gemfibrozil—Neuritis—Doxorubicin—thyroid cancer	0.00156	0.0039	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00156	0.00389	CcSEcCtD
Gemfibrozil—Fatigue—Vandetanib—thyroid cancer	0.00156	0.00389	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Sorafenib—thyroid cancer	0.00155	0.00386	CcSEcCtD
Gemfibrozil—Pain—Vandetanib—thyroid cancer	0.00154	0.00386	CcSEcCtD
Gemfibrozil—Constipation—Vandetanib—thyroid cancer	0.00154	0.00386	CcSEcCtD
Gemfibrozil—PPARA—PPAR Alpha Pathway—CCND1—thyroid cancer	0.00152	0.0118	CbGpPWpGaD
Gemfibrozil—Alopecia—Sorafenib—thyroid cancer	0.00152	0.00378	CcSEcCtD
Gemfibrozil—Mental disorder—Sorafenib—thyroid cancer	0.0015	0.00375	CcSEcCtD
Gemfibrozil—Hyperaesthesia—Doxorubicin—thyroid cancer	0.00149	0.00371	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00148	0.00369	CcSEcCtD
Gemfibrozil—SLCO1B1—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.00147	0.0114	CbGpPWpGaD
Gemfibrozil—CYP2C9—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00147	0.0114	CbGpPWpGaD
Gemfibrozil—Dysgeusia—Sorafenib—thyroid cancer	0.00146	0.00365	CcSEcCtD
Gemfibrozil—Jaundice cholestatic—Epirubicin—thyroid cancer	0.00144	0.00359	CcSEcCtD
Gemfibrozil—Abdominal pain—Vandetanib—thyroid cancer	0.00143	0.00356	CcSEcCtD
Gemfibrozil—PPARA—Transcriptional regulation of white adipocyte differentiation—RXRA—thyroid cancer	0.00142	0.011	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian Clock—HIF1A—thyroid cancer	0.00138	0.0107	CbGpPWpGaD
Gemfibrozil—Anaemia—Sorafenib—thyroid cancer	0.00138	0.00344	CcSEcCtD
Gemfibrozil—Angioedema—Sorafenib—thyroid cancer	0.00136	0.00341	CcSEcCtD
Gemfibrozil—Syncope—Sorafenib—thyroid cancer	0.00134	0.00334	CcSEcCtD
Gemfibrozil—Leukopenia—Sorafenib—thyroid cancer	0.00134	0.00334	CcSEcCtD
Gemfibrozil—Blood bilirubin increased—Epirubicin—thyroid cancer	0.00133	0.00333	CcSEcCtD
Gemfibrozil—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.00133	0.00332	CcSEcCtD
Gemfibrozil—Loss of consciousness—Sorafenib—thyroid cancer	0.00131	0.00328	CcSEcCtD
Gemfibrozil—Cough—Sorafenib—thyroid cancer	0.0013	0.00325	CcSEcCtD
Gemfibrozil—Asthenia—Vandetanib—thyroid cancer	0.0013	0.00324	CcSEcCtD
Gemfibrozil—Pruritus—Vandetanib—thyroid cancer	0.00128	0.00319	CcSEcCtD
Gemfibrozil—Musculoskeletal pain—Epirubicin—thyroid cancer	0.00128	0.00319	CcSEcCtD
Gemfibrozil—Arthralgia—Sorafenib—thyroid cancer	0.00127	0.00317	CcSEcCtD
Gemfibrozil—Myalgia—Sorafenib—thyroid cancer	0.00127	0.00317	CcSEcCtD
Gemfibrozil—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.00127	0.00984	CbGpPWpGaD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00126	0.00315	CcSEcCtD
Gemfibrozil—Phosphatase alkaline increased—Epirubicin—thyroid cancer	0.00126	0.00315	CcSEcCtD
Gemfibrozil—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00125	0.00974	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00125	0.00969	CbGpPWpGaD
Gemfibrozil—Diarrhoea—Vandetanib—thyroid cancer	0.00124	0.00309	CcSEcCtD
Gemfibrozil—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.00123	0.00308	CcSEcCtD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.00123	0.00952	CbGpPWpGaD
Gemfibrozil—Anaphylactic shock—Sorafenib—thyroid cancer	0.00122	0.00304	CcSEcCtD
Gemfibrozil—Colitis—Epirubicin—thyroid cancer	0.00121	0.00303	CcSEcCtD
Gemfibrozil—Shock—Sorafenib—thyroid cancer	0.0012	0.00299	CcSEcCtD
Gemfibrozil—Nervous system disorder—Sorafenib—thyroid cancer	0.00119	0.00298	CcSEcCtD
Gemfibrozil—Dizziness—Vandetanib—thyroid cancer	0.00119	0.00298	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Sorafenib—thyroid cancer	0.00119	0.00298	CcSEcCtD
Gemfibrozil—Skin disorder—Sorafenib—thyroid cancer	0.00118	0.00295	CcSEcCtD
Gemfibrozil—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00118	0.00295	CcSEcCtD
Gemfibrozil—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	0.00117	0.00292	CcSEcCtD
Gemfibrozil—Vomiting—Vandetanib—thyroid cancer	0.00115	0.00287	CcSEcCtD
Gemfibrozil—Rash—Vandetanib—thyroid cancer	0.00114	0.00284	CcSEcCtD
Gemfibrozil—Dermatitis—Vandetanib—thyroid cancer	0.00114	0.00284	CcSEcCtD
Gemfibrozil—Headache—Vandetanib—thyroid cancer	0.00113	0.00282	CcSEcCtD
Gemfibrozil—Colitis—Doxorubicin—thyroid cancer	0.00112	0.0028	CcSEcCtD
Gemfibrozil—PPARA—Orphan transporters—RXRA—thyroid cancer	0.00112	0.00868	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00111	0.00863	CbGpPWpGaD
Gemfibrozil—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00111	0.00277	CcSEcCtD
Gemfibrozil—Nausea—Vandetanib—thyroid cancer	0.00107	0.00268	CcSEcCtD
Gemfibrozil—Dyspepsia—Sorafenib—thyroid cancer	0.00107	0.00268	CcSEcCtD
Gemfibrozil—PPARA—PPARA activates gene expression—RXRA—thyroid cancer	0.00107	0.0083	CbGpPWpGaD
Gemfibrozil—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.00105	0.00263	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00105	0.00263	CcSEcCtD
Gemfibrozil—Fatigue—Sorafenib—thyroid cancer	0.00105	0.00262	CcSEcCtD
Gemfibrozil—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—thyroid cancer	0.00105	0.00812	CbGpPWpGaD
Gemfibrozil—Photosensitivity—Epirubicin—thyroid cancer	0.00104	0.0026	CcSEcCtD
Gemfibrozil—Constipation—Sorafenib—thyroid cancer	0.00104	0.0026	CcSEcCtD
Gemfibrozil—Pain—Sorafenib—thyroid cancer	0.00104	0.0026	CcSEcCtD
Gemfibrozil—Eczema—Epirubicin—thyroid cancer	0.00102	0.00255	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000996	0.00249	CcSEcCtD
Gemfibrozil—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.000974	0.00243	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000971	0.00242	CcSEcCtD
Gemfibrozil—Urticaria—Sorafenib—thyroid cancer	0.000968	0.00242	CcSEcCtD
Gemfibrozil—Photosensitivity—Doxorubicin—thyroid cancer	0.000965	0.00241	CcSEcCtD
Gemfibrozil—Abdominal pain—Sorafenib—thyroid cancer	0.000963	0.0024	CcSEcCtD
Gemfibrozil—Eczema—Doxorubicin—thyroid cancer	0.000943	0.00235	CcSEcCtD
Gemfibrozil—PPARA—Adipogenesis—RXRA—thyroid cancer	0.000936	0.00726	CbGpPWpGaD
Gemfibrozil—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000898	0.00224	CcSEcCtD
Gemfibrozil—PPARA—Transcriptional regulation of white adipocyte differentiation—PPARG—thyroid cancer	0.000898	0.00697	CbGpPWpGaD
Gemfibrozil—Asthenia—Sorafenib—thyroid cancer	0.000874	0.00218	CcSEcCtD
Gemfibrozil—Pruritus—Sorafenib—thyroid cancer	0.000862	0.00215	CcSEcCtD
Gemfibrozil—PPARA—Organelle biogenesis and maintenance—RXRA—thyroid cancer	0.000857	0.00666	CbGpPWpGaD
Gemfibrozil—Liver function test abnormal—Epirubicin—thyroid cancer	0.000846	0.00211	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Epirubicin—thyroid cancer	0.000837	0.00209	CcSEcCtD
Gemfibrozil—Diarrhoea—Sorafenib—thyroid cancer	0.000833	0.00208	CcSEcCtD
Gemfibrozil—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000831	0.00645	CbGpPWpGaD
Gemfibrozil—Breast disorder—Epirubicin—thyroid cancer	0.000828	0.00207	CcSEcCtD
Gemfibrozil—CYP2C8—Metapathway biotransformation—CHST14—thyroid cancer	0.000821	0.00638	CbGpPWpGaD
Gemfibrozil—Nasopharyngitis—Epirubicin—thyroid cancer	0.000819	0.00205	CcSEcCtD
Gemfibrozil—Muscular weakness—Epirubicin—thyroid cancer	0.000808	0.00202	CcSEcCtD
Gemfibrozil—Dizziness—Sorafenib—thyroid cancer	0.000806	0.00201	CcSEcCtD
Gemfibrozil—PPARA—Generic Transcription Pathway—THRB—thyroid cancer	0.000804	0.00624	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000795	0.00617	CbGpPWpGaD
Gemfibrozil—Eosinophilia—Epirubicin—thyroid cancer	0.000784	0.00196	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000782	0.00195	CcSEcCtD
Gemfibrozil—Pancreatitis—Epirubicin—thyroid cancer	0.000776	0.00194	CcSEcCtD
Gemfibrozil—Vomiting—Sorafenib—thyroid cancer	0.000775	0.00193	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000774	0.00193	CcSEcCtD
Gemfibrozil—Rash—Sorafenib—thyroid cancer	0.000768	0.00192	CcSEcCtD
Gemfibrozil—Dermatitis—Sorafenib—thyroid cancer	0.000767	0.00192	CcSEcCtD
Gemfibrozil—Breast disorder—Doxorubicin—thyroid cancer	0.000766	0.00191	CcSEcCtD
Gemfibrozil—Headache—Sorafenib—thyroid cancer	0.000763	0.00191	CcSEcCtD
Gemfibrozil—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000758	0.00589	CbGpPWpGaD
Gemfibrozil—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000758	0.00588	CbGpPWpGaD
Gemfibrozil—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000758	0.00189	CcSEcCtD
Gemfibrozil—Pancytopenia—Epirubicin—thyroid cancer	0.000752	0.00188	CcSEcCtD
Gemfibrozil—Muscular weakness—Doxorubicin—thyroid cancer	0.000748	0.00187	CcSEcCtD
Gemfibrozil—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.000733	0.00569	CbGpPWpGaD
Gemfibrozil—Eosinophilia—Doxorubicin—thyroid cancer	0.000725	0.00181	CcSEcCtD
Gemfibrozil—Nausea—Sorafenib—thyroid cancer	0.000724	0.00181	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000723	0.0018	CcSEcCtD
Gemfibrozil—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000721	0.0056	CbGpPWpGaD
Gemfibrozil—Pancreatitis—Doxorubicin—thyroid cancer	0.000718	0.00179	CcSEcCtD
Gemfibrozil—Weight decreased—Epirubicin—thyroid cancer	0.000716	0.00179	CcSEcCtD
Gemfibrozil—Pancytopenia—Doxorubicin—thyroid cancer	0.000696	0.00174	CcSEcCtD
Gemfibrozil—PPARA—Adipogenesis—HIF1A—thyroid cancer	0.000695	0.00539	CbGpPWpGaD
Gemfibrozil—Renal failure—Epirubicin—thyroid cancer	0.000694	0.00173	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000692	0.00173	CcSEcCtD
Gemfibrozil—Jaundice—Epirubicin—thyroid cancer	0.000688	0.00172	CcSEcCtD
Gemfibrozil—Urinary tract infection—Epirubicin—thyroid cancer	0.000686	0.00171	CcSEcCtD
Gemfibrozil—PPARA—PPARA activates gene expression—PPARG—thyroid cancer	0.000675	0.00524	CbGpPWpGaD
Gemfibrozil—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000669	0.00167	CcSEcCtD
Gemfibrozil—CYP2C9—Metapathway biotransformation—CHST14—thyroid cancer	0.000669	0.00519	CbGpPWpGaD
Gemfibrozil—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000668	0.00167	CcSEcCtD
Gemfibrozil—Weight decreased—Doxorubicin—thyroid cancer	0.000663	0.00165	CcSEcCtD
Gemfibrozil—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	0.000661	0.00513	CbGpPWpGaD
Gemfibrozil—Renal failure—Doxorubicin—thyroid cancer	0.000642	0.0016	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00064	0.0016	CcSEcCtD
Gemfibrozil—Jaundice—Doxorubicin—thyroid cancer	0.000637	0.00159	CcSEcCtD
Gemfibrozil—Rhinitis—Epirubicin—thyroid cancer	0.000635	0.00159	CcSEcCtD
Gemfibrozil—Urinary tract infection—Doxorubicin—thyroid cancer	0.000635	0.00159	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Epirubicin—thyroid cancer	0.00063	0.00157	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Epirubicin—thyroid cancer	0.000623	0.00155	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000618	0.00154	CcSEcCtD
Gemfibrozil—Eye disorder—Epirubicin—thyroid cancer	0.000592	0.00148	CcSEcCtD
Gemfibrozil—PPARA—Adipogenesis—PPARG—thyroid cancer	0.000591	0.00459	CbGpPWpGaD
Gemfibrozil—Rhinitis—Doxorubicin—thyroid cancer	0.000588	0.00147	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000583	0.00146	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000576	0.00144	CcSEcCtD
Gemfibrozil—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	0.000571	0.00443	CbGpPWpGaD
Gemfibrozil—Mediastinal disorder—Epirubicin—thyroid cancer	0.000571	0.00143	CcSEcCtD
Gemfibrozil—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000563	0.00437	CbGpPWpGaD
Gemfibrozil—Alopecia—Epirubicin—thyroid cancer	0.00056	0.0014	CcSEcCtD
Gemfibrozil—Mental disorder—Epirubicin—thyroid cancer	0.000555	0.00139	CcSEcCtD
Gemfibrozil—PPARA—Metabolism—MINPP1—thyroid cancer	0.000549	0.00427	CbGpPWpGaD
Gemfibrozil—Eye disorder—Doxorubicin—thyroid cancer	0.000548	0.00137	CcSEcCtD
Gemfibrozil—Flatulence—Epirubicin—thyroid cancer	0.000544	0.00136	CcSEcCtD
Gemfibrozil—Tension—Epirubicin—thyroid cancer	0.000541	0.00135	CcSEcCtD
Gemfibrozil—Dysgeusia—Epirubicin—thyroid cancer	0.00054	0.00135	CcSEcCtD
Gemfibrozil—Nervousness—Epirubicin—thyroid cancer	0.000536	0.00134	CcSEcCtD
Gemfibrozil—PPARA—Gene Expression—TRIM33—thyroid cancer	0.000536	0.00416	CbGpPWpGaD
Gemfibrozil—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000528	0.00132	CcSEcCtD
Gemfibrozil—Vision blurred—Epirubicin—thyroid cancer	0.00052	0.0013	CcSEcCtD
Gemfibrozil—Alopecia—Doxorubicin—thyroid cancer	0.000518	0.00129	CcSEcCtD
Gemfibrozil—Mental disorder—Doxorubicin—thyroid cancer	0.000514	0.00128	CcSEcCtD
Gemfibrozil—PPARA—Generic Transcription Pathway—MEN1—thyroid cancer	0.000511	0.00396	CbGpPWpGaD
Gemfibrozil—Anaemia—Epirubicin—thyroid cancer	0.00051	0.00127	CcSEcCtD
Gemfibrozil—Flatulence—Doxorubicin—thyroid cancer	0.000503	0.00126	CcSEcCtD
Gemfibrozil—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000503	0.0039	CbGpPWpGaD
Gemfibrozil—Tension—Doxorubicin—thyroid cancer	0.000501	0.00125	CcSEcCtD
Gemfibrozil—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.0005	0.00388	CbGpPWpGaD
Gemfibrozil—Dysgeusia—Doxorubicin—thyroid cancer	0.0005	0.00125	CcSEcCtD
Gemfibrozil—Nervousness—Doxorubicin—thyroid cancer	0.000496	0.00124	CcSEcCtD
Gemfibrozil—Vertigo—Epirubicin—thyroid cancer	0.000496	0.00124	CcSEcCtD
Gemfibrozil—Syncope—Epirubicin—thyroid cancer	0.000495	0.00124	CcSEcCtD
Gemfibrozil—Leukopenia—Epirubicin—thyroid cancer	0.000494	0.00123	CcSEcCtD
Gemfibrozil—Loss of consciousness—Epirubicin—thyroid cancer	0.000485	0.00121	CcSEcCtD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000482	0.00374	CbGpPWpGaD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000482	0.00374	CbGpPWpGaD
Gemfibrozil—Cough—Epirubicin—thyroid cancer	0.000481	0.0012	CcSEcCtD
Gemfibrozil—Vision blurred—Doxorubicin—thyroid cancer	0.000481	0.0012	CcSEcCtD
Gemfibrozil—Convulsion—Epirubicin—thyroid cancer	0.000478	0.00119	CcSEcCtD
Gemfibrozil—Anaemia—Doxorubicin—thyroid cancer	0.000472	0.00118	CcSEcCtD
Gemfibrozil—Arthralgia—Epirubicin—thyroid cancer	0.00047	0.00117	CcSEcCtD
Gemfibrozil—Chest pain—Epirubicin—thyroid cancer	0.00047	0.00117	CcSEcCtD
Gemfibrozil—Myalgia—Epirubicin—thyroid cancer	0.00047	0.00117	CcSEcCtD
Gemfibrozil—PPARA—Metabolism—NDUFA13—thyroid cancer	0.000467	0.00363	CbGpPWpGaD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000466	0.00116	CcSEcCtD
Gemfibrozil—Vertigo—Doxorubicin—thyroid cancer	0.000459	0.00115	CcSEcCtD
Gemfibrozil—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000458	0.00356	CbGpPWpGaD
Gemfibrozil—Syncope—Doxorubicin—thyroid cancer	0.000458	0.00114	CcSEcCtD
Gemfibrozil—Leukopenia—Doxorubicin—thyroid cancer	0.000457	0.00114	CcSEcCtD
Gemfibrozil—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000457	0.00354	CbGpPWpGaD
Gemfibrozil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000456	0.00354	CbGpPWpGaD
Gemfibrozil—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	0.000455	0.00353	CbGpPWpGaD
Gemfibrozil—Confusional state—Epirubicin—thyroid cancer	0.000454	0.00113	CcSEcCtD
Gemfibrozil—Oedema—Epirubicin—thyroid cancer	0.00045	0.00112	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Epirubicin—thyroid cancer	0.00045	0.00112	CcSEcCtD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000449	0.00348	CbGpPWpGaD
Gemfibrozil—Loss of consciousness—Doxorubicin—thyroid cancer	0.000449	0.00112	CcSEcCtD
Gemfibrozil—Cough—Doxorubicin—thyroid cancer	0.000445	0.00111	CcSEcCtD
Gemfibrozil—Shock—Epirubicin—thyroid cancer	0.000443	0.00111	CcSEcCtD
Gemfibrozil—Convulsion—Doxorubicin—thyroid cancer	0.000442	0.0011	CcSEcCtD
Gemfibrozil—Nervous system disorder—Epirubicin—thyroid cancer	0.000441	0.0011	CcSEcCtD
Gemfibrozil—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000441	0.00342	CbGpPWpGaD
Gemfibrozil—Thrombocytopenia—Epirubicin—thyroid cancer	0.000441	0.0011	CcSEcCtD
Gemfibrozil—PPARA—Metabolism—CHST14—thyroid cancer	0.000439	0.00341	CbGpPWpGaD
Gemfibrozil—Skin disorder—Epirubicin—thyroid cancer	0.000437	0.00109	CcSEcCtD
Gemfibrozil—Myalgia—Doxorubicin—thyroid cancer	0.000435	0.00109	CcSEcCtD
Gemfibrozil—Chest pain—Doxorubicin—thyroid cancer	0.000435	0.00109	CcSEcCtD
Gemfibrozil—Arthralgia—Doxorubicin—thyroid cancer	0.000435	0.00109	CcSEcCtD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000434	0.00337	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—CP—thyroid cancer	0.000434	0.00337	CbGpPWpGaD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000432	0.00108	CcSEcCtD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000427	0.00332	CbGpPWpGaD
Gemfibrozil—Confusional state—Doxorubicin—thyroid cancer	0.00042	0.00105	CcSEcCtD
Gemfibrozil—PPARA—Circadian rythm related genes—PPARG—thyroid cancer	0.000417	0.00324	CbGpPWpGaD
Gemfibrozil—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000417	0.00104	CcSEcCtD
Gemfibrozil—Oedema—Doxorubicin—thyroid cancer	0.000417	0.00104	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00041	0.00102	CcSEcCtD
Gemfibrozil—Shock—Doxorubicin—thyroid cancer	0.00041	0.00102	CcSEcCtD
Gemfibrozil—Nervous system disorder—Doxorubicin—thyroid cancer	0.000409	0.00102	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000408	0.00102	CcSEcCtD
Gemfibrozil—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000408	0.00316	CbGpPWpGaD
Gemfibrozil—Skin disorder—Doxorubicin—thyroid cancer	0.000405	0.00101	CcSEcCtD
Gemfibrozil—Paraesthesia—Epirubicin—thyroid cancer	0.000404	0.00101	CcSEcCtD
Gemfibrozil—Somnolence—Epirubicin—thyroid cancer	0.0004	0.000999	CcSEcCtD
Gemfibrozil—Dyspepsia—Epirubicin—thyroid cancer	0.000396	0.00099	CcSEcCtD
Gemfibrozil—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000392	0.00304	CbGpPWpGaD
Gemfibrozil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.00039	0.00302	CbGpPWpGaD
Gemfibrozil—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000389	0.00097	CcSEcCtD
Gemfibrozil—Fatigue—Epirubicin—thyroid cancer	0.000388	0.000969	CcSEcCtD
Gemfibrozil—PPARA—Gene Expression—THRB—thyroid cancer	0.000387	0.00301	CbGpPWpGaD
Gemfibrozil—Pain—Epirubicin—thyroid cancer	0.000385	0.000961	CcSEcCtD
Gemfibrozil—Constipation—Epirubicin—thyroid cancer	0.000385	0.000961	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00038	0.000948	CcSEcCtD
Gemfibrozil—Paraesthesia—Doxorubicin—thyroid cancer	0.000374	0.000934	CcSEcCtD
Gemfibrozil—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000372	0.00288	CbGpPWpGaD
Gemfibrozil—Feeling abnormal—Epirubicin—thyroid cancer	0.000371	0.000926	CcSEcCtD
Gemfibrozil—Somnolence—Doxorubicin—thyroid cancer	0.00037	0.000925	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000368	0.000919	CcSEcCtD
Gemfibrozil—Dyspepsia—Doxorubicin—thyroid cancer	0.000367	0.000916	CcSEcCtD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000361	0.0028	CbGpPWpGaD
Gemfibrozil—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00036	0.000898	CcSEcCtD
Gemfibrozil—Fatigue—Doxorubicin—thyroid cancer	0.000359	0.000897	CcSEcCtD
Gemfibrozil—Urticaria—Epirubicin—thyroid cancer	0.000358	0.000893	CcSEcCtD
Gemfibrozil—Pain—Doxorubicin—thyroid cancer	0.000356	0.000889	CcSEcCtD
Gemfibrozil—Constipation—Doxorubicin—thyroid cancer	0.000356	0.000889	CcSEcCtD
Gemfibrozil—Abdominal pain—Epirubicin—thyroid cancer	0.000356	0.000889	CcSEcCtD
Gemfibrozil—PPARA—Metabolism—HPGD—thyroid cancer	0.000354	0.00275	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—CDK1—thyroid cancer	0.000346	0.00269	CbGpPWpGaD
Gemfibrozil—Feeling abnormal—Doxorubicin—thyroid cancer	0.000343	0.000857	CcSEcCtD
Gemfibrozil—PPARA—Generic Transcription Pathway—RXRA—thyroid cancer	0.000342	0.00265	CbGpPWpGaD
Gemfibrozil—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000341	0.000851	CcSEcCtD
Gemfibrozil—Urticaria—Doxorubicin—thyroid cancer	0.000331	0.000826	CcSEcCtD
Gemfibrozil—Abdominal pain—Doxorubicin—thyroid cancer	0.000329	0.000822	CcSEcCtD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000325	0.00252	CbGpPWpGaD
Gemfibrozil—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000324	0.00251	CbGpPWpGaD
Gemfibrozil—Asthenia—Epirubicin—thyroid cancer	0.000323	0.000807	CcSEcCtD
Gemfibrozil—PPARA—Developmental Biology—RXRA—thyroid cancer	0.000322	0.0025	CbGpPWpGaD
Gemfibrozil—Pruritus—Epirubicin—thyroid cancer	0.000319	0.000795	CcSEcCtD
Gemfibrozil—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000318	0.00246	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—MINPP1—thyroid cancer	0.00031	0.00241	CbGpPWpGaD
Gemfibrozil—Diarrhoea—Epirubicin—thyroid cancer	0.000308	0.000769	CcSEcCtD
Gemfibrozil—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000302	0.00235	CbGpPWpGaD
Gemfibrozil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000301	0.00233	CbGpPWpGaD
Gemfibrozil—Asthenia—Doxorubicin—thyroid cancer	0.000299	0.000746	CcSEcCtD
Gemfibrozil—Dizziness—Epirubicin—thyroid cancer	0.000298	0.000743	CcSEcCtD
Gemfibrozil—Pruritus—Doxorubicin—thyroid cancer	0.000295	0.000736	CcSEcCtD
Gemfibrozil—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000289	0.00224	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000287	0.00223	CbGpPWpGaD
Gemfibrozil—Vomiting—Epirubicin—thyroid cancer	0.000286	0.000715	CcSEcCtD
Gemfibrozil—PPARA—Circadian rythm related genes—PTEN—thyroid cancer	0.000286	0.00222	CbGpPWpGaD
Gemfibrozil—Diarrhoea—Doxorubicin—thyroid cancer	0.000285	0.000712	CcSEcCtD
Gemfibrozil—Rash—Epirubicin—thyroid cancer	0.000284	0.000709	CcSEcCtD
Gemfibrozil—Dermatitis—Epirubicin—thyroid cancer	0.000284	0.000708	CcSEcCtD
Gemfibrozil—Headache—Epirubicin—thyroid cancer	0.000282	0.000704	CcSEcCtD
Gemfibrozil—Dizziness—Doxorubicin—thyroid cancer	0.000275	0.000688	CcSEcCtD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000273	0.00212	CbGpPWpGaD
Gemfibrozil—Nausea—Epirubicin—thyroid cancer	0.000267	0.000668	CcSEcCtD
Gemfibrozil—Vomiting—Doxorubicin—thyroid cancer	0.000265	0.000661	CcSEcCtD
Gemfibrozil—SLCO1B1—Metabolism—NDUFA13—thyroid cancer	0.000264	0.00205	CbGpPWpGaD
Gemfibrozil—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000263	0.00204	CbGpPWpGaD
Gemfibrozil—Rash—Doxorubicin—thyroid cancer	0.000263	0.000656	CcSEcCtD
Gemfibrozil—Dermatitis—Doxorubicin—thyroid cancer	0.000262	0.000655	CcSEcCtD
Gemfibrozil—PPARA—Gene Expression—TPR—thyroid cancer	0.000262	0.00203	CbGpPWpGaD
Gemfibrozil—Headache—Doxorubicin—thyroid cancer	0.000261	0.000652	CcSEcCtD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000258	0.002	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CHST14—thyroid cancer	0.000248	0.00192	CbGpPWpGaD
Gemfibrozil—Nausea—Doxorubicin—thyroid cancer	0.000247	0.000618	CcSEcCtD
Gemfibrozil—PPARA—Gene Expression—MEN1—thyroid cancer	0.000246	0.00191	CbGpPWpGaD
Gemfibrozil—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000245	0.0019	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000245	0.0019	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000245	0.0019	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—RXRA—thyroid cancer	0.000243	0.00188	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000241	0.00187	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000241	0.00187	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00023	0.00179	CbGpPWpGaD
Gemfibrozil—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000225	0.00175	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—RXRA—thyroid cancer	0.000216	0.00168	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—PPARG—thyroid cancer	0.000216	0.00167	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00021	0.00163	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—TPR—thyroid cancer	0.000203	0.00158	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—PPARG—thyroid cancer	0.000203	0.00158	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PRKAR1A—thyroid cancer	0.0002	0.00155	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—HPGD—thyroid cancer	0.0002	0.00155	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—RXRA—thyroid cancer	0.000197	0.00153	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—TP53—thyroid cancer	0.000195	0.00152	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000187	0.00145	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000183	0.00142	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000181	0.00141	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000179	0.00139	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—MINPP1—thyroid cancer	0.000178	0.00138	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—RXRA—thyroid cancer	0.000169	0.00131	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—RXRA—thyroid cancer	0.000164	0.00128	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000162	0.00126	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000161	0.00125	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—MINPP1—thyroid cancer	0.000159	0.00123	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000154	0.0012	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—SLC5A5—thyroid cancer	0.000152	0.00118	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NDUFA13—thyroid cancer	0.000151	0.00118	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—MINPP1—thyroid cancer	0.000145	0.00113	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000143	0.00111	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CHST14—thyroid cancer	0.000142	0.00111	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000137	0.00106	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NDUFA13—thyroid cancer	0.000135	0.00105	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—RXRA—thyroid cancer	0.00013	0.00101	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—RXRA—thyroid cancer	0.000128	0.000993	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CHST14—thyroid cancer	0.000127	0.000987	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000124	0.000966	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—NRAS—thyroid cancer	0.000124	0.000965	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—MINPP1—thyroid cancer	0.000124	0.000962	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NDUFA13—thyroid cancer	0.000123	0.000957	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CHST14—thyroid cancer	0.000116	0.0009	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—HPGD—thyroid cancer	0.000115	0.000891	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—TPR—thyroid cancer	0.000115	0.000891	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	0.000113	0.000876	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—KRAS—thyroid cancer	0.000107	0.00083	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NDUFA13—thyroid cancer	0.000105	0.000818	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—PPARG—thyroid cancer	0.000104	0.000806	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—HPGD—thyroid cancer	0.000102	0.000796	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000102	0.000794	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CHST14—thyroid cancer	9.91e-05	0.000769	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MINPP1—thyroid cancer	9.56e-05	0.000742	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—HPGD—thyroid cancer	9.34e-05	0.000725	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.31e-05	0.000723	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—HRAS—thyroid cancer	9.09e-05	0.000706	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	8.59e-05	0.000667	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	8.31e-05	0.000645	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NDUFA13—thyroid cancer	8.13e-05	0.000631	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PPARG—thyroid cancer	8.08e-05	0.000627	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.05e-05	0.000625	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—AKT1—thyroid cancer	8.03e-05	0.000623	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HPGD—thyroid cancer	7.98e-05	0.00062	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CHST14—thyroid cancer	7.65e-05	0.000593	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.58e-05	0.000588	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—RXRA—thyroid cancer	7.22e-05	0.00056	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.02e-05	0.000545	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—TPR—thyroid cancer	6.59e-05	0.000512	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	6.49e-05	0.000504	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.48e-05	0.000503	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PTGS2—thyroid cancer	6.35e-05	0.000493	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HPGD—thyroid cancer	6.16e-05	0.000478	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—TPR—thyroid cancer	5.89e-05	0.000457	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.88e-05	0.000456	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	5.79e-05	0.000449	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PTEN—thyroid cancer	5.54e-05	0.00043	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—TPR—thyroid cancer	5.37e-05	0.000417	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	5.28e-05	0.00041	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.25e-05	0.000407	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SLC5A5—thyroid cancer	4.94e-05	0.000383	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.79e-05	0.000371	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.63e-05	0.000359	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—TPR—thyroid cancer	4.59e-05	0.000356	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PPARG—thyroid cancer	4.56e-05	0.000354	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	4.51e-05	0.00035	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC5A5—thyroid cancer	4.41e-05	0.000342	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—RXRA—thyroid cancer	4.15e-05	0.000322	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.13e-05	0.00032	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—AKT1—thyroid cancer	4.11e-05	0.000319	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.09e-05	0.000317	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.03e-05	0.000313	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC5A5—thyroid cancer	4.02e-05	0.000312	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.76e-05	0.000292	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—RXRA—thyroid cancer	3.7e-05	0.000287	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.6e-05	0.00028	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTGS2—thyroid cancer	3.58e-05	0.000278	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—TPR—thyroid cancer	3.54e-05	0.000275	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	3.48e-05	0.00027	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC5A5—thyroid cancer	3.43e-05	0.000267	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—RXRA—thyroid cancer	3.38e-05	0.000262	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.28e-05	0.000255	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.22e-05	0.00025	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—AKT1—thyroid cancer	3.19e-05	0.000248	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTEN—thyroid cancer	3.13e-05	0.000243	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—RXRA—thyroid cancer	2.88e-05	0.000224	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.81e-05	0.000218	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC5A5—thyroid cancer	2.65e-05	0.000206	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PPARG—thyroid cancer	2.62e-05	0.000203	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PPARG—thyroid cancer	2.34e-05	0.000181	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—RXRA—thyroid cancer	2.23e-05	0.000173	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PPARG—thyroid cancer	2.13e-05	0.000165	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTGS2—thyroid cancer	2.06e-05	0.00016	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTGS2—thyroid cancer	1.84e-05	0.000143	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PPARG—thyroid cancer	1.82e-05	0.000141	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—AKT1—thyroid cancer	1.8e-05	0.00014	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTEN—thyroid cancer	1.8e-05	0.000139	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTGS2—thyroid cancer	1.68e-05	0.00013	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTEN—thyroid cancer	1.6e-05	0.000124	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTEN—thyroid cancer	1.46e-05	0.000113	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTGS2—thyroid cancer	1.43e-05	0.000111	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PPARG—thyroid cancer	1.41e-05	0.000109	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTEN—thyroid cancer	1.25e-05	9.7e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.11e-05	8.58e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—AKT1—thyroid cancer	1.04e-05	8.04e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTEN—thyroid cancer	9.64e-06	7.49e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—AKT1—thyroid cancer	9.24e-06	7.17e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—AKT1—thyroid cancer	8.43e-06	6.54e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—AKT1—thyroid cancer	7.2e-06	5.59e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—AKT1—thyroid cancer	5.56e-06	4.31e-05	CbGpPWpGaD
